Advancing Preclinical Predictivity
At MIMETAS, we disrupt the approach to preclinical research. Our human organ models empower pharmaceutical researchers in the fields of toxicology and ADME, enabling expedited safety and efficacy assessments of compounds.
3D Tissue Models for Precise Preclinical Toxicology
Unlocking the secrets of human physiology has long been a challenge in toxicity studies. However, our revolutionary technology now provides a breakthrough solution. By harnessing advanced human tissue and disease models with diverse quantitative assessments, researchers can delve into drug-induced toxicity with unparalleled relevance to human physiology for efficient risk management strategy. Unmanageable toxicity accounts for 30% of clinical drug development failures, primarily attributed to the limitation of traditional models in accurately reflecting human physiology.